Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
Oesophageal cancer, Stomach cancer
Closed
Phase 3
This trial is looking at adding durvalumab to chemotherapy for people having surgery to remove their cancer.
It is open to people with:
Recruitment start: 5 June 2021
Recruitment end: 5 July 2022
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Elizabeth Smyth
AstraZeneca
Last reviewed: 15 September 2022
CRUK internal database number: 17684